Femasys Inc., a leading biomedical innovator in women's health, announced its intention to offer and sell shares of its common stock in a public offering, with the option for underwriters to purchase an additional 15% of the shares. Concurrently, certain existing institutional stockholders and company directors and officers have shown interest in a private placement of shares. The offerings aim to fund the company's commercial expansion, product development, and general corporate purposes. JonesTrading Institutional Services LLC is managing the public offering and private placement. The public offering is registered under a statement filed with the U.S. Securities and Exchange Commission.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.